By Karen Roman
ReAlta Life Sciences, Inc. said it designated Ellen Lubman as Chief Business Officer to supervise business development, capital formation and corporate strategy.
Ms. Lubman has nearly 25 years of experience across small to large-cap private and public biopharmaceutical companies with a track record in strategic, transactional, and operational roles, the company stated. She previously served as Chief Business Officer at Werewolf Therapeutics, Inc. (Nasdaq: HOWL), taking the company through multiple financings including an IPO, it said.
“Ellen is a highly respected executive with a strong track record of building partnerships, raising capital, and developing successful corporate strategies for biotech and pharmaceutical companies,” said David Marek, ReAlta’s CEO. “We are excited to welcome Ellen at such a pivotal moment for our business with all three clinical programs reading out this year.”
Ms. Lubman holds an M.B.A. from Stanford Graduate School of Business and a B.A. in Biology from Rutgers College.
READ MORE
ReAlta Drug Shows Promise in Protecting Newborn Brains from Oxygen Deprivation Injuries
Never Miss our Weekly Highlights HERE
Contact:
Exec Edge
Editor@executives-edge.com
Click HERE to follow us on LinkedIn
